Literature DB >> 15356994

Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin.

Jen-Kun Lin1.   

Abstract

Curcumin (diferuloylmethane) is a major naturally-occurring polyphenol of Curcuma species, which is commonly used as a yellow coloring and flavoring agent in foods. Curcumin has shown anti-carcinogenic activity in animal models. Curcumin possesses anti-inflammatory activity and is a potent inhibitor of reactive oxygen-generating enzymes such as lipoxygenase/cyclooxygenase, xanthine dehydrogenase/oxidase and inducible nitric oxide synthase; and an effective inducer of heme oxygenase-1. Curcumin is also a potent inhibitor of protein kinase C (PKC), EGF(Epidermal growth factor)-receptor tyrosine kinase and IkappaB kinase. Subsequently, curcumin inhibits the activation of NF(nucleor factor)kappaB and the expressions of oncogenes including c-jun, c-fos, c-myc, NIK, MAPKs, ERK, ELK, PI3K, Akt, CDKs and iNOS. It is proposed that curcumin may suppress tumor promotion through blocking signal transduction pathways in the target cells. The oxidant tumor promoter TPA activates PKC by reacting with zinc thiolates present within the regulatory domain, while the oxidized form of cancer chemopreventive agent such as curcumin can inactivate PKC by oxidizing the vicinal thiols present within the catalytic domain. Recent studies indicated that proteasome-mediated degradation of cell proteins play a pivotal role in the regulation of several basic cellular processes including differentiation, proliferation, cell cycling, and apoptosis. It has been demonstrated that curcumin-induced apoptosis is mediated through the impairment of ubiquitin-proteasome pathway. Curcumin was first biotransformed to dihydrocurcumin and tetrahydrocurcumin and that these compounds subsequently were converted to monoglucuronide conjugates. These results suggest that curcumin-glucuronide, dihydrocurcumin-glucuronide, tetrahydrocurcumin-glucuronide and tetrahydrocurcumin are the major metabolites of curcumin in mice, rats and humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356994     DOI: 10.1007/bf02980135

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  13 in total

1.  Ethyl caffeate suppresses NF-kappaB activation and its downstream inflammatory mediators, iNOS, COX-2, and PGE2 in vitro or in mouse skin.

Authors:  Yi-Ming Chiang; Chiu-Ping Lo; Yi-Ping Chen; Sheng-Yang Wang; Ning-Sun Yang; Yueh-Hsiung Kuo; Lie-Fen Shyur
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 2.  Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing.

Authors:  Muobarak Jaber Tuorkey
Journal:  Interv Med Appl Sci       Date:  2014-12-22

Review 3.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

Review 4.  Chemoprevention of head and neck cancer with green tea polyphenols.

Authors:  Joseph W Kim; A R M Ruhul Amin; Dong M Shin
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-27

5.  Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.

Authors:  Huang-Ge Zhang; Helen Kim; Cunren Liu; Shaohua Yu; Jianhua Wang; William E Grizzle; Robert P Kimberly; Stephen Barnes
Journal:  Biochim Biophys Acta       Date:  2007-05-01

6.  Targeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model.

Authors:  Nikhil K Basu; Labanyamoy Kole; Mousumi Basu; Antony F McDonagh; Ida S Owens
Journal:  Biochem Biophys Res Commun       Date:  2007-06-14       Impact factor: 3.575

7.  Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening.

Authors:  Xiaohong Liu; Kai Sun; Ailin Song; Xiaoyun Zhang; Xu Zhang; Xiaodong He
Journal:  World J Surg Oncol       Date:  2014-12-19       Impact factor: 2.754

8.  Curcumin Induces Apoptosis in EJ Bladder Cancer Cells via Modulating C-Myc and PI3K/Akt Signaling Pathway.

Authors:  Jingyu Wang; Zhiping Wang; Hanzhang Wang; Junli Zhao; Zhewen Zhang
Journal:  World J Oncol       Date:  2011-06-08

9.  Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer.

Authors:  Laura E Wright; Jen B Frye; Bhavana Gorti; Barbara N Timmermann; Janet L Funk
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Anti cancer effects of curcumin: cycle of life and death.

Authors:  Gaurisankar Sa; Tanya Das
Journal:  Cell Div       Date:  2008-10-03       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.